Shikimate Pathway Enzymes

Plants and microorganisms rely on the shikimate pathway to produce essential aromatic compounds, especially the aromatic amino acids (Phe, Tyr, and Trp). Because mammals, including humans, obtain these amino acids through the diet, they do not produce the enzymes of the shikimate pathway, making these attractive targets for new antitubercular agents. We are working to identify and characterize new compounds that inhibit both shikimate dehydrogenase and shikimate kinase (see below). These enzymes catalyze two consecutive steps in the pathway, and simultaneous inhibition of both targets is anticipated to limit development of resistance to antibiotics based on these leads. We are bringing multiple computational and experimental tools to bear on this problem, including docking, molecular dynamics, enzyme binding and inhibition kinetics, X-ray crystallography, targeted intrinsic protein fluorescence, and 19-F NMR.


Overlaid ribbon
        structures of M. tuberculosis shikimate kinase. Open (no
        shikimate) versus closed (with shikimate)

Image: Ribbon structure representation of shikimate kinase.
The open structure (without shikimate) is shown in gray.
The closed stucture (with shikimate [sk] and ATP) is shown in blue.